CN103933198A - Active mineral ion eye drops - Google Patents
Active mineral ion eye drops Download PDFInfo
- Publication number
- CN103933198A CN103933198A CN201410167873.1A CN201410167873A CN103933198A CN 103933198 A CN103933198 A CN 103933198A CN 201410167873 A CN201410167873 A CN 201410167873A CN 103933198 A CN103933198 A CN 103933198A
- Authority
- CN
- China
- Prior art keywords
- parts
- organic
- eye drops
- hydrosol
- active mineral
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 229910052500 inorganic mineral Inorganic materials 0.000 title claims abstract description 15
- 239000011707 mineral Substances 0.000 title claims abstract description 15
- 239000003889 eye drop Substances 0.000 title abstract description 9
- 229940012356 eye drops Drugs 0.000 title abstract description 9
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims abstract description 51
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 claims abstract description 16
- 229910001424 calcium ion Inorganic materials 0.000 claims abstract description 16
- 239000000843 powder Substances 0.000 claims abstract description 15
- 240000004385 Centaurea cyanus Species 0.000 claims abstract description 14
- 235000005940 Centaurea cyanus Nutrition 0.000 claims abstract description 14
- 150000002500 ions Chemical class 0.000 claims abstract description 13
- 239000007788 liquid Substances 0.000 claims description 17
- 238000003756 stirring Methods 0.000 claims description 15
- 239000000284 extract Substances 0.000 claims description 14
- 241000628997 Flos Species 0.000 claims description 13
- 239000008131 herbal destillate Substances 0.000 claims description 12
- 238000005352 clarification Methods 0.000 claims description 10
- 238000002156 mixing Methods 0.000 claims description 10
- 239000000203 mixture Substances 0.000 claims description 7
- 238000002360 preparation method Methods 0.000 claims description 6
- 230000001954 sterilising effect Effects 0.000 claims description 6
- 210000001508 eye Anatomy 0.000 abstract description 37
- 230000000694 effects Effects 0.000 abstract description 6
- 230000004438 eyesight Effects 0.000 abstract description 4
- 206010061218 Inflammation Diseases 0.000 abstract description 3
- 230000004054 inflammatory process Effects 0.000 abstract description 3
- 239000004615 ingredient Substances 0.000 abstract description 2
- 210000001328 optic nerve Anatomy 0.000 abstract description 2
- 240000003538 Chamaemelum nobile Species 0.000 abstract 1
- 235000007866 Chamaemelum nobile Nutrition 0.000 abstract 1
- 235000007232 Matricaria chamomilla Nutrition 0.000 abstract 1
- 230000003467 diminishing effect Effects 0.000 abstract 1
- 235000020647 eyebright extract Nutrition 0.000 abstract 1
- 230000002349 favourable effect Effects 0.000 abstract 1
- 239000000243 solution Substances 0.000 description 13
- 210000004027 cell Anatomy 0.000 description 9
- 235000010755 mineral Nutrition 0.000 description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- 230000006378 damage Effects 0.000 description 6
- 208000005494 xerophthalmia Diseases 0.000 description 5
- 210000001519 tissue Anatomy 0.000 description 4
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 3
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 3
- 239000003242 anti bacterial agent Substances 0.000 description 3
- 230000002421 anti-septic effect Effects 0.000 description 3
- 229940088710 antibiotic agent Drugs 0.000 description 3
- 208000003464 asthenopia Diseases 0.000 description 3
- 239000011575 calcium Substances 0.000 description 3
- 229910052791 calcium Inorganic materials 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 238000004821 distillation Methods 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 229930003944 flavone Natural products 0.000 description 3
- 150000002212 flavone derivatives Chemical group 0.000 description 3
- 235000011949 flavones Nutrition 0.000 description 3
- 208000015181 infectious disease Diseases 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 3
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 208000010412 Glaucoma Diseases 0.000 description 2
- 208000003251 Pruritus Diseases 0.000 description 2
- 239000004098 Tetracycline Substances 0.000 description 2
- WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 description 2
- 229940097572 chloromycetin Drugs 0.000 description 2
- 239000003246 corticosteroid Substances 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 235000019364 tetracycline Nutrition 0.000 description 2
- 150000003522 tetracyclines Chemical class 0.000 description 2
- 230000001256 tonic effect Effects 0.000 description 2
- PXFBZOLANLWPMH-UHFFFAOYSA-N 16-Epiaffinine Natural products C1C(C2=CC=CC=C2N2)=C2C(=O)CC2C(=CC)CN(C)C1C2CO PXFBZOLANLWPMH-UHFFFAOYSA-N 0.000 description 1
- 206010002198 Anaphylactic reaction Diseases 0.000 description 1
- 229930003347 Atropine Natural products 0.000 description 1
- 208000032170 Congenital Abnormalities Diseases 0.000 description 1
- 235000002673 Dioscorea communis Nutrition 0.000 description 1
- 241000544230 Dioscorea communis Species 0.000 description 1
- 206010015946 Eye irritation Diseases 0.000 description 1
- 206010052139 Eye oedema Diseases 0.000 description 1
- RKUNBYITZUJHSG-UHFFFAOYSA-N Hyosciamin-hydrochlorid Natural products CN1C(C2)CCC1CC2OC(=O)C(CO)C1=CC=CC=C1 RKUNBYITZUJHSG-UHFFFAOYSA-N 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 241000282376 Panthera tigris Species 0.000 description 1
- 208000035753 Periorbital contusion Diseases 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 230000036783 anaphylactic response Effects 0.000 description 1
- 208000003455 anaphylaxis Diseases 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- -1 antiviral class Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- RKUNBYITZUJHSG-SPUOUPEWSA-N atropine Chemical compound O([C@H]1C[C@H]2CC[C@@H](C1)N2C)C(=O)C(CO)C1=CC=CC=C1 RKUNBYITZUJHSG-SPUOUPEWSA-N 0.000 description 1
- 229960000396 atropine Drugs 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000001185 bone marrow Anatomy 0.000 description 1
- 210000005252 bulbus oculi Anatomy 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 150000001735 carboxylic acids Chemical class 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 210000000795 conjunctiva Anatomy 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 231100000433 cytotoxic Toxicity 0.000 description 1
- 230000001472 cytotoxic effect Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000004043 dyeing Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 231100000013 eye irritation Toxicity 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 210000002175 goblet cell Anatomy 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 230000008595 infiltration Effects 0.000 description 1
- 238000001764 infiltration Methods 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 230000002427 irreversible effect Effects 0.000 description 1
- 206010023683 lagophthalmos Diseases 0.000 description 1
- 239000002932 luster Substances 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- VUZPPFZMUPKLLV-UHFFFAOYSA-N methane;hydrate Chemical compound C.O VUZPPFZMUPKLLV-UHFFFAOYSA-N 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000003472 neutralizing effect Effects 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000020477 pH reduction Effects 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 229920002338 polyhydroxyethylmethacrylate Polymers 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 238000005096 rolling process Methods 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 229940124530 sulfonamide Drugs 0.000 description 1
- 150000003456 sulfonamides Chemical class 0.000 description 1
- JLKIGFTWXXRPMT-UHFFFAOYSA-N sulphamethoxazole Chemical compound O1C(C)=CC(NS(=O)(=O)C=2C=CC(N)=CC=2)=N1 JLKIGFTWXXRPMT-UHFFFAOYSA-N 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 229960002180 tetracycline Drugs 0.000 description 1
- 229930101283 tetracycline Natural products 0.000 description 1
- 229940040944 tetracyclines Drugs 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 230000008728 vascular permeability Effects 0.000 description 1
- 230000009978 visual deterioration Effects 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
The invention relates to active mineral ion eye drops. The eye drops include the following components: 1-9 parts of calcium ion powder, 1-5parts of an eyebright extract, 40-50 parts of organic cornflower hydrolat, 40-50 parts of organic chamomile hydrolat and 1-3 parts of citric acid. The active mineral ion eye drops disclosed by the invention are prepared from pure natural ingredients, and have the functions of diminishing inflammation, moistening and improving eyesight; the eye drops are healthy, caring and free from side effects; the eye drops can protect optic nerve, and are favorable for people, such as modern television users and computer users, whose eyes easily feel fatigued.
Description
Technical field
The present invention relates to, particularly a kind of active mineral ion profit eye liquid.
Background technology
Along with the change of people's life style and working condition, more and more with the time of eye, for example see for a long time computer, see TV, operate video games etc., as easy as rolling off a log trouble visual fatigue disease and xerophthalmia.It is main manifestations that these two kinds of diseases all be take the dry and astringent discomfort of eyes, the involuntary necessary article that becomes office clan of collyrium, a lot of artificial alleviate malaise symptoms variable interval drip two, in fact do very and endanger like this.For keeping the aseptic of medicine and the effect duration of prolong drug, all add antiseptic to guarantee the quality.Owing to mostly containing antiseptic in collyrium, can make the Conjunctival Goblet Cells in eyes damage.As conjunctiva cup-shaped, wherein general cell is impaired, and people will suffer from xerophthalmia, and rubescent, the dry and astringent or pain of eyes, can cause more applying eye drops in eyes, the more dry pain of eyes like this.Corticosteroid glaucoma collyrium, according to therapeutic efficiency, is divided into many types, and as antibiotics, antiviral class, hormones etc., improper use will cause damage to people.For example hormones collyrium, if used too much, can make people suffer from corticosteroid glaucoma unconsciously, causes people's visual deterioration, and vision and the visual field sustain damage.This damage is irreversible, substantially there is no the possibility taking a turn for the better.In addition, antibiotics collyrium can only have for eyes the situation of infection, while not infecting, uses, and only can cause damage to eyes., there are several collyrium to pay particular attention to, atropine eye liquid, sulfamethoxazole sodium are broad spectrum antibiotic; Accidental eye irritation or anaphylaxis.Antibiotics collyrium can only have for eyes the situation of infection, while not infecting, uses, and only can cause damage to eyes.Chloramphenicol-type collyrium, because chloromycetin has serious bone marrow inhibition, anemia of pregnant woman may cause neonate to produce serious untoward reaction after using, and Tetracyclines collyrium easily causes fetal anomaly.
It is composite that current existing collyrium and eye drops mostly are pharmaceutical compositions, and maximum improvement is also to select in medicine to add comparatively gentle moistening composition again, has reduced the zest to eyes.But for collyrium, eye drops main component be, sulfonamides, chloromycetin, tetracycline, antiseptic, antioxidant etc.
Summary of the invention
For the defect existing in prior art, the object of the present invention is to provide a kind of active mineral ion profit eye liquid.
Technical scheme of the present invention is as follows:
An active mineral ion profit eye liquid, composed of the following components:
Calcium ion powder 1-9 part, Herba Euphrasiae Regelii extract 1-5 part, organic Centaurea cyanus hydrosol 40-50 part, organic Flos Matricariae chamomillae hydrosol 40-50 part, citric acid 1-3 part.
On the basis of such scheme, described profit eye liquid is composed of the following components:
5 parts of calcium ion powders, 3 parts of Herba Euphrasiae Regelii extracts, 45 parts of organic Centaurea cyanus hydrosols, 45 parts of organic Flos Matricariae chamomillae hydrosols, 2 parts of citric acid.
An active mineral ion profit eye liquid, concrete preparation method is as follows:
1) take according to quantity each component in above-mentioned composition;
2) calcium ion powder is joined in organic Centaurea cyanus hydrosol, uniform stirring, 35 revs/min of mixing speeds, to the solution clarification obtaining;
3) Herba Euphrasiae Regelii extract and citric acid are joined in organic Flos Matricariae chamomillae hydrosol, uniform stirring, 35 revs/min of mixing speeds, to the solution clarification obtaining;
4) by step 2) and 3) solution prepared mixes, uniform stirring 10 minutes, high-temp steam sterilizing.
In compositions of the present invention, each component is as follows:
Calcium ion powder:
Mineral and the trace element such as the calcium that contains needed by human body, magnesium, potassium, sodium, ferrum, zinc, selenium, phosphorus are the most easily only absorbed by human body under ionic condition.Calcium ion powder aqueous solution is alkalescence, and pH value is 7.5-8.5, and medical research shows, during alkalescence energy is rapid, with the interior various acidic metabolites of body, prevents body constitution acidification.Alkalescence body constitution is the uncomfortable survival environmental conditionses of pathogenic bacterium, removes various diseases hidden danger.Due to calcium ion can neutralizing acid poison, active cell, and antibacterial cannot be survived, therefore can make inflammation phenomenon rapidly disappear.The water clusters of ionized calcium is comprised of 5-7 hydrone, and the water clusters of human body cell is comprised of 6 hydrones, and water clusters is similar to coincide.The easy affine cell tissue that is penetrated into, active cell. enhance metabolism, get rid of cytotoxic element. the rubbish in tissue.Ionized calcium electronegative potential, current potential is between negative 200-250mV.Can be human body cell and tissue provides electronics, make cell have more oxidation resistance, remove free radical, Cell protection DNA and tissue are avoided infringement, thereby improve human immunologic function.Antioxidation can stop degeneration, aging, the anti-eye strain of cell, improves eye function, promotes vision.
Manufacturer: Taiwan Jin Budan group.
Herba Euphrasiae Regelii extract:
Protect eye tonic and astringent, helpful especially for the deflation of eyes muscle, inflammation, infection, allergy or other ophthalmic; It can also alleviate the many tear of eye, aches and itch symptom.Herba Euphrasiae Regelii is appointed as natural eye protection tonic by doctor in Europe, has the title of " collyrium that can drink ".Main effective ingredient is flavone (flavone), Herba Euphrasiae Regelii flavone.
Manufacturer: Yuan Sen bio tech ltd, Xi'an
Organic Centaurea cyanus hydrosol:
Be four kinds and can be used for one of hydrosol cleaning eyes, when eyes occur tired, swelling or scratch where it itches, can also can be used as the succedaneum of collyrium with its soak in the surface of skin, in numerous hydrosols, its scope of application is the widest.
It is by distillation fragrant plant that hydrosol is referred to as again Hua Shui (Hydrosols & Floral Water), more a kind of water quality product that freeze-out after cooling.The overwhelming majority who comprises in this hydrosol is the aqueous molecule of plant, and quintessence oil molecule exists hardly.And its fragrance and quintessence oil also have larger gap, its color and luster and water colour are as good as.In addition, by the hydrosol that distills, without any substance, can not produce a large amount of foams because rocking.
Extracting process: distillation
Fabrication portion; Flower
PH-value: PH4.5-5.0
Manufacturer: Xiang Yuan Asia, Hong Kong company limited goods number: HORCO_A.
Organic Flos Matricariae chamomillae hydrosol
There are very excellent convergence and purifying functions, are four kinds and onlyly can clean one of hydrosol of eyes.Can eliminate eye edema, receive trickle blood vessel by Enough, releive because of black eye tired or that do not have enough sleep and cause.
Extracting process: distillation
Fabrication portion; Flower
PH-value: PH4.5-5.0
Manufacturer: Xiang Yuan Asia, Hong Kong company limited goods number: HORCG_A.
Citric acid:
Citric acid is citric acid.Citric acid is a kind of tricarboxylic acidsization chemistry compound, and therefore has similar physics and chemistry character to other carboxylic acids.While being heated to 175 ℃, it can decompose generation carbon dioxide and water, remains some white crystals.There is sterilization, short infiltration, the effect of adjustment vascular permeability.
Active particle of the present invention profit eye liquid, is prepared from by pure natural components, has antiinflammatory, and the effect of moistening, improving eyesight, is free from side effects at health, maintenance, protects optic nerve, and advance TV family, cybraian etc. are easily caused to the crowd of eyestrain has tonification.
The specific embodiment
Embodiment 1
An active mineral ion profit eye liquid, composed of the following components:
1 part of calcium ion powder, 1 part of Herba Euphrasiae Regelii extract, 40 parts of organic Centaurea cyanus hydrosols, 40 parts of organic Flos Matricariae chamomillae hydrosols, 1 part of citric acid.
Concrete preparation method is as follows:
1) take according to quantity each component in above-mentioned composition;
2) calcium ion powder is joined in organic Centaurea cyanus hydrosol, uniform stirring, 35 revs/min of mixing speeds, to the solution clarification obtaining;
3) Herba Euphrasiae Regelii extract and citric acid are joined in organic Flos Matricariae chamomillae hydrosol, uniform stirring, 35 revs/min of mixing speeds, to the solution clarification obtaining;
4) by step 2) and 3) solution prepared mixes, uniform stirring 10 minutes, high-temp steam sterilizing.
Embodiment 2
An active mineral ion profit eye liquid, composed of the following components:
5 parts of calcium ion powders, 3 parts of Herba Euphrasiae Regelii extracts, 45 parts of organic Centaurea cyanus hydrosols, 45 parts of organic Flos Matricariae chamomillae hydrosols, 2 parts of citric acid.
Concrete preparation method is as follows:
1) take according to quantity each component in above-mentioned composition;
2) calcium ion powder is joined in organic Centaurea cyanus hydrosol, uniform stirring, 35 revs/min of mixing speeds, to the solution clarification obtaining;
3) Herba Euphrasiae Regelii extract and citric acid are joined in organic Flos Matricariae chamomillae hydrosol, uniform stirring, 35 revs/min of mixing speeds, to the solution clarification obtaining;
4) by step 2) and 3) solution prepared mixes, uniform stirring 10 minutes, high-temp steam sterilizing.
Embodiment 3
An active mineral ion profit eye liquid, composed of the following components:
9 parts of calcium ion powders, 5 parts of Herba Euphrasiae Regelii extracts, 50 parts of organic Centaurea cyanus hydrosols, 50 parts of organic Flos Matricariae chamomillae hydrosols, 3 parts of citric acid.
Concrete preparation method is as follows:
1) take according to quantity each component in above-mentioned composition;
2) calcium ion powder is joined in organic Centaurea cyanus hydrosol, uniform stirring, 35 revs/min of mixing speeds, to the solution clarification obtaining;
3) Herba Euphrasiae Regelii extract and citric acid are joined in organic Flos Matricariae chamomillae hydrosol, uniform stirring, 35 revs/min of mixing speeds, to the solution clarification obtaining;
4) by step 2) and 3) solution prepared mixes, uniform stirring 10 minutes, high-temp steam sterilizing.
Clinical trial
The treatment of profit eye liquid to xerophthalmia:
Extract the lachrymal gland of lagophthalmos, merge and use 0.1% bromogeramine solution to carry out xerophthalmia modeling.
Treatment group gives the profit eye liquid of embodiment 2 preparations and treats, and 3 times/d, model group gives normal saline, and 3 times/d, continuous 14d; Apparent the examining and brave red corneal dyeing of eye.
Result: compared with the tested eye of model group gently, the red painted score value of tiger is compared all carrying out property minimizings with matched group for treatment group bloodshot eyes, edema symptom.
Above-mentioned experimental result shows, profit eye liquid prepared by the inventive method can by lubricated to the moisturizing of eyeball and etc. approach xerophthalmia is played to certain alleviation and improvement effect.
Claims (3)
1. active mineral ion moistens an eye liquid, it is characterized in that composed of the following components:
Calcium ion powder 1-9 part, Herba Euphrasiae Regelii extract 1-5 part, organic Centaurea cyanus hydrosol 40-50 part, organic Flos Matricariae chamomillae hydrosol 40-50 part, citric acid 1-3 part.
2. a kind of active mineral ion according to claim 1 moistens eye liquid, it is characterized in that composed of the following components:
5 parts of calcium ion powders, 3 parts of Herba Euphrasiae Regelii extracts, 45 parts of organic Centaurea cyanus hydrosols, 45 parts of organic Flos Matricariae chamomillae hydrosols, 2 parts of citric acid.
3. a kind of active mineral ion according to claim 1 and 2 moistens eye liquid, it is characterized in that concrete preparation method is as follows:
1) take according to quantity each component in above-mentioned composition;
2) calcium ion powder is joined in organic Centaurea cyanus hydrosol, uniform stirring, 35 revs/min of mixing speeds, to the solution clarification obtaining;
3) Herba Euphrasiae Regelii extract and citric acid are joined in organic Flos Matricariae chamomillae hydrosol, uniform stirring, 35 revs/min of mixing speeds, to the solution clarification obtaining;
4) by step 2) and 3) solution prepared mixes, uniform stirring 10 minutes, high-temp steam sterilizing.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410167873.1A CN103933198B (en) | 2014-04-24 | 2014-04-24 | A kind of active mineral ion profit eye liquid |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410167873.1A CN103933198B (en) | 2014-04-24 | 2014-04-24 | A kind of active mineral ion profit eye liquid |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN103933198A true CN103933198A (en) | 2014-07-23 |
| CN103933198B CN103933198B (en) | 2016-03-09 |
Family
ID=51181255
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410167873.1A Expired - Fee Related CN103933198B (en) | 2014-04-24 | 2014-04-24 | A kind of active mineral ion profit eye liquid |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103933198B (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106963672A (en) * | 2016-11-18 | 2017-07-21 | 广州宏韵医药科技股份有限公司 | It is a kind of that there is alleviation visual fatigue and the near the eyes composition of skin cell fatigue and its application |
| CN109908198A (en) * | 2019-04-24 | 2019-06-21 | 嘉兴力山明朗生物医药科技有限公司 | A kind of corn flower collyrium |
| CN109908199A (en) * | 2019-04-24 | 2019-06-21 | 嘉兴力山明朗生物医药科技有限公司 | A kind of chamomile collyrium |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1872211A (en) * | 2006-04-29 | 2006-12-06 | 倪友洪 | Medication products of containing euphrasy, and preparation method |
| CN101468114A (en) * | 2007-12-28 | 2009-07-01 | 沃德（天津）营养保健品有限公司 | Product for protecting vision and method for preparing the same |
-
2014
- 2014-04-24 CN CN201410167873.1A patent/CN103933198B/en not_active Expired - Fee Related
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1872211A (en) * | 2006-04-29 | 2006-12-06 | 倪友洪 | Medication products of containing euphrasy, and preparation method |
| CN101468114A (en) * | 2007-12-28 | 2009-07-01 | 沃德（天津）营养保健品有限公司 | Product for protecting vision and method for preparing the same |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106963672A (en) * | 2016-11-18 | 2017-07-21 | 广州宏韵医药科技股份有限公司 | It is a kind of that there is alleviation visual fatigue and the near the eyes composition of skin cell fatigue and its application |
| CN106963672B (en) * | 2016-11-18 | 2020-03-31 | 广州宏韵医药科技股份有限公司 | Composition capable of relieving visual fatigue and periocular skin cell fatigue and application thereof |
| CN109908198A (en) * | 2019-04-24 | 2019-06-21 | 嘉兴力山明朗生物医药科技有限公司 | A kind of corn flower collyrium |
| CN109908199A (en) * | 2019-04-24 | 2019-06-21 | 嘉兴力山明朗生物医药科技有限公司 | A kind of chamomile collyrium |
Also Published As
| Publication number | Publication date |
|---|---|
| CN103933198B (en) | 2016-03-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR101478945B1 (en) | Shampoo composition containing native plant extracts and natural oriental material extracts | |
| CN106333885A (en) | Plant extract and eye essence liquid | |
| CN104825351A (en) | Eaglewood whitening facial cleanser and preparation method thereof | |
| CN106421695A (en) | Traditional Chinese medicine composition for eye care | |
| CN105902418A (en) | Imitated sebum matrix, external preparation including imitated sebum matrix and application thereof | |
| CN107184448A (en) | A kind of acne eliminating cream that there is prevention pockmark to generate | |
| KR101810229B1 (en) | Cosmetic composition for improving acne containing teatree leaves spicule powder | |
| CN103933198B (en) | A kind of active mineral ion profit eye liquid | |
| KR102220534B1 (en) | Soothing cream and manufacturing method for the same | |
| KR100962534B1 (en) | Soap composition comprising herb extracts | |
| CN105106318A (en) | Traditional Chinese medicine composition for treating xerophthalmia and preparation method of traditional Chinese medicine composition | |
| KR20160046024A (en) | Soap cure natural composition for scalp | |
| CN106822233A (en) | Improve product of xerophthalmia and preparation method thereof | |
| CN104188854A (en) | Nutritional alcohol-free nourishing astringent lotion | |
| CN106994148A (en) | A kind of anti acne of traditional Chinese medicine preparation | |
| KR100505486B1 (en) | Fiber with biological material and its manufacturing method | |
| CN103565688A (en) | Healthcare facial milk and preparation method thereof | |
| CN102764416B (en) | Formula and preparation method of hair blackening preparation | |
| CN102847030A (en) | Freckle-removal facial mask | |
| CN106265301A (en) | Sun screen containing Flos Matricariae chamomillae | |
| CN111110817A (en) | Traditional Chinese medicine composition for treating eye diseases, preparation method and application thereof | |
| CN105687047A (en) | Makeup removing cream with anti-allergy effect and preparation method thereof | |
| CN104474137A (en) | Organic extract eye moistening liquid and preparation method thereof | |
| CN105311400A (en) | Formula for treating unclear vision due to kidney-yin deficiency | |
| CN104435128A (en) | Pure natural organic extract eye drops and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20160309 |